Biochemical relapse-free survival
WebAt a median follow-up time of 21 months (range, 6–32 months), the median biochemical progression-free survival was 19 months (range, 4 to 23 months) in the radiotherapy group, as compared with 16.5 months (range, 4 to 28 months) in the surgery group. WebApr 11, 2024 · Purpose To investigate whether whole pelvic radiotherapy (WPRT) improves biochemical relapse-free survival (bRFS) vs. prostate bed radiotherapy (PBRT) in …
Biochemical relapse-free survival
Did you know?
WebDec 17, 2024 · Purpose Conditional survival represents the probability of subsequent survival given that patients have already survived a certain length of time. Several models predict biochemical recurrence (BCR) … WebOct 19, 2015 · Biochemical progression-free survival in localized prostate cancer patients treated with definitive external beam radiotherapy Electron Physician. 2015 Oct 19;7 (6):1330-5. doi: 10.14661/1330. eCollection 2015 Oct. Authors Afshin Rakhsha 1 , Amir Shahram Yousefi Kashi 1 , Bahram Mofid 2 , Mohammad Houshyari 1 Affiliations
WebOur nomograms provide biochemical recurrence-free survival probability, which is easier to explain to patients. The most important distinction of our models is that we integrated a … WebJan 7, 2024 · Biochemical relapse-free survival (BRFS) is the most commonly used endpoint to evaluate the efficacy of local treatments in clinical studies of prostate cancer (PCa) [2,3,4]. Other variables, such as the clinical course after biochemical failure (BF), the recurrence pattern, and the impact of this pattern on survival outcomes have received ...
WebMar 17, 2024 · Survival analysis depicted a median biochemical progression-free survival of 18 months (range, 4 to 28 months) in the study population, with a biochemical progression-free survival rate of 71.7% at one year out of 53 patients followed for at … WebProgression Free Survival. Progression free survival (PFS) was similar between non-diabetics and diabetics on Met. ... and 10-year local control rates after RP alone in such patients are about 85% and about 61%. 732-739 Overall clinical and biochemical relapse-free rates are also improved with adjuvant RT, 733-735,738-740 which generally ...
WebAim: Biochemical relapse-free survival (bRFS) rate is determined by a cohort of Mexican patients (n = 595) with prostate cancer who received treatment with external …
WebBRFS, biochemical recurrence-free survival (Kaplan-Meier curve analysis). We found that the biochemical recurrence-free survivals differed between the group of patients who reached a PSA nadir less than 0.1 ng/ml (undetectable) versus patients who did not reached a undetectable serum PSA (73% vs. 30%, logrank = 7.11, P = 0.0076). northern sagebrush lizardWebde la Taille et al [28] recently reported a biochemical failure-free survival rate of 66% at 12 months in a series of 43 salvage patients, with low complication rates. In their … northern safety supply usaWebi. introduction..... 1 ii. background ..... how to run filebeat in linuxWebTwo retrospective series compared biochemical recurrence-free survival between patients older and younger than 75 and older and younger than 60, respectively, and … northern saints jfcnorthern sales and manufacturing pine riverWebApr 12, 2024 · Biochemical recurrence 3 years posttherapy with PSA = 0.37. (A) Four hours image and (B) 24 h image show a 3 mm right external iliac metastatic lymph node (SUV max = 8). (C) The node (arrow) on the axial CT scan. ... linked to other outcome measures such as biochemical recurrence-free survival. 22, ... northern saints basketball clubWebThere were 110 and 163 patients who experienced clinical recurrence and biochemical recurrence, respectively, with clinical recurrence-free and biochemical recurrence-free survival at 10 years of 31% and 11%, respectively. After salvage lymph node dissection, a total of 145 patients received ADT, with a median time to ADT of 41 months: northernsaints.com